ICECAP试验中各中心温度控制实践的差异性
该研究为横断面调查,评估ICECAP试验(NCT04217551)中各中心温度控制实践。问卷回复率75%(n=51),80%中心有温度控制方案,62.5%有急诊科独立启动方案,68.6%有镇静或神经肌肉阻滞管理方案。诱导期神经肌肉阻滞使用差异大,61.7%中心使用率低于20%;83.3%方案强调早期启动,但最大障碍为临床虚无主义(62.5%)。ICECAP数据库显示约半数患者接受神经肌肉阻滞,使用率和启动时间各中心差异大。作者认为需定义和标准化高质量温度控制。
要点
- ICECAP试验各中心温度控制资源、方法和早期启动障碍差异显著,需定义和标准化高质量温度控制。
- 80%(n=41)中心有温度控制方案,62.5%(n=32)有急诊科独立启动方案,68.6%(n=35)有镇静或神经肌肉阻滞管理方案。
- 诱导期神经肌肉阻滞使用差异大,61.7%(n=29)中心使用率低于20%。
- 83.3%(n=11)方案强调早期启动温度控制,但最大障碍为临床虚无主义(n=30,62.5%)。
- ICECAP数据库中约半数患者接受神经肌肉阻滞,使用率和启动时间各中心差异大。
适用人群与场景
- 参与ICECAP试验(NCT04217551)的各中心成年心脏骤停患者。
处置流程与药物剂量
- 各中心温度控制方案:80%(n=41)有机构方案,62.5%(n=32)有急诊科独立启动方案,68.6%(n=35)有镇静或神经肌肉阻滞管理方案。
- 诱导期神经肌肉阻滞使用:61.7%(n=29)中心使用率低于20%。
- ICECAP数据库中约半数患者接受神经肌肉阻滞,使用率和启动时间各中心差异大。
研究设计与关键结果
- 横断面调查研究,评估ICECAP试验中各中心温度控制实践,问卷回复率75%(n=51),23.5%(n=12)上传机构方案。
- 80%(n=41)中心有温度控制方案,62.5%(n=32)有急诊科独立启动方案,68.6%(n=35)有镇静或神经肌肉阻滞管理方案。
- 诱导期神经肌肉阻滞使用差异大,61.7%(n=29)中心使用率低于20%。
- 83.3%(n=11)机构方案强调早期启动温度控制,但最大障碍为临床虚无主义(n=30,62.5%)。
- ICECAP数据库中约半数患者接受神经肌肉阻滞,使用率和启动时间各中心差异大。
证据类型、等级与局限
- 证据类型:横断面调查研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,定义和标准化高质量温度控制应被优先考虑,因其可能影响过去和当前临床试验结果的解读。
指南或共识出处
- ICECAP试验(NCT04217551)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: Temperature control is a complex bundled intervention; the synergistic impact of each individual component is ill defined and underreported. Resultantly, the influence of parameter optimization on temperature control's overall neuroprotective effect remains poorly understood. To characterize variability in temperature control parameters and barriers to short pre-induction and induction times, we surveyed sites enrolling in an ongoing multicenter clinical trial.
METHODS: This was a cross-sectional, survey study evaluating temperature control practices within the Influence of Cooling duration on Efficacy in Cardiac Arrest Patients (ICECAP) trial (NCT04217551). A 23-question web-based survey (Qualtrics) was distributed to the site principal investigators by email. Respondents were asked about site practices pertaining to the use of temperature control, including the request to upload individual institutional protocols. Open-ended responses were analyzed qualitatively by categorizing responses into identified themes. To complement survey level data, records pertaining to the quality of temperature control were extracted from the ICECAP trial database.
RESULTS: The survey response rate was 75% (n = 51) including 23.5% (n = 12) survey respondents who uploaded institutional protocols. Most sites reported having institutional protocols for temperature control (n = 41; 80%), including 62.5% (n = 32) who had separate protocols for initiation of temperature control in the emergency department (ED). Fewer sites had protocols specific to sedation or neuromuscular blockade (NMB) management (n = 35, 68.6%). Use of NMB during temperature control induction was variable; 61.7% (n = 29) of sites induced paralysis less than 20% of the time. While most institutional protocols (n = 11, 83.3%) commented on the importance of early initiation of temperature control, this was incongruent with the largest reported barrier, which was clinical nihilism regarding the importance of early temperature control initiation (n = 30, 62.5%). Within the ICECAP trial database, 1 in 2 patients were treated with NMB however, use of NMB and time to initiation of temperature control device varied widely between sites.
CONCLUSION: Amongst ICECAP trial sites, there was significant variability in resources, methods, and barriers for early temperature control initiation. Defining and standardizing high-quality temperature control must be prioritized, as it may impact the interpretation of past and current clinical trial findings.
参考来源
- Beekman R, Perman SM, Nguyen C, et al. Variability in temperature control practices amongst the Influence of Cooling duration on Efficacy in Cardiac Arrest Patients (ICECAP) trial. Resuscitation. 2024. PMID: 39278393. doi:10.1016/j.resuscitation.2024.110397
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。